Consistent with previously reported unchanged immune cell compositions, IL-1β, a potent pro-inflammatory cytokine, is induced slightly during the early phase (1–4 weeks) of tumor progression (Fig. 4A-B). The gene discussed is IL1B; the disease is neoplasm.